This IDPC advocacy note elaborates what a health-based approach looks like in practice in Africa, and explores five specific areas that need to be urgently addressed by governments.
Despite widespread implementation of compulsory treatment modalities for drug dependence, there has so far been no systematic evaluation of the scientific evidence on the effectiveness of compulsory drug treatment.
This analysis raises concerns about the UN evaluation of the drug situation in Africa given its reliance on quantitative data that is instrumentalised, manipulated and of limited availability.
This article discusses the possible solutions to the problem of teenage gang members involved in drug trafficking, those that are most vulnerable and visible in the trade chain.
This briefing paper highlights some relevant issues for the UNGASS debate concerning strategies for addressing drug crop production as a development issue.
For the first time, the Regional Dialogue brought together representatives of governments of EECA countries, civil society organizations, key populations and communities, international organisations and technical agencies with the goal of discussing commitments and principles of the successful transition from donor to national funding of HIV and TB responses.
HRI, EHRN, ARF and the Canadian HIV/AIDS Legal Network view this inquiry as a significant time to draw attention to the importance of prioritising health and human rights of Russian people who use drugs within the context of broader discussions on the UK bilateral relations with Russia.
This TNI report analyses the counter-narcotics efforts and policies in Afghanistan and examines the interplay of political actors since the military intervention in 2001.
The Board is presenting this report about the availability of internationally controlled drugs to Member States, in the hope that the analysis and recommendations presented may assist them in the development of national policies and control systems that are capable of achieving the goals of the international drug control conventions.
The UK's new Psychoactive Substance Act will virtually be a "blanket ban" on the production, supply or offer of all psychoactive substances and will come into effect in April of this year.
